BUSINESS● LOWAug 13 · Aug 13, 2026, 12:33 PM
Fate Therapeutics GAAP EPS of -$0.25 beats by $0.02, revenue of $2.08M beats by $0.81M
Seeking Alpha Tech
Fate Therapeutics reported GAAP EPS of -$0.25, beating expectations by $0.02, and revenue of $2.08M, surpassing estimates by $0.81M. This indicates the company's financial results outperformed projections.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS22m agoFifth Third expects 2.5%-3.5% Q4 net interest income growth as it targets $200M-$300M buybacksSeeking Alpha TechBUSINESS33m agoServisFirst outlines 5-7 bps quarterly margin expansion as it launches 2m-share repurchase planSeeking Alpha Tech